Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
Sysmex Corp.
| Company | Sysmex Corp. |
|---|---|
| Name of analyzer | pocH-100i |
| Contact | Madelaine Dintelman |
| City, State | Lincolnshire, IL |
| Phone | 888-879-7639 |
| Website | |
| Analyzer application | diagnostic use |
| Dimensions of analyzer (H × W × | 10.1 × 7.3 × 13.8 in./— |
| Country where analyzer was | Japan/Japan |
| First year analyzer was sold in U.S./Approximate No. of units installed in U.S.* | 2004/>2, 000 |
| First year analyzer sold outside | 2003/>5, 000 |
| Foreign locations where company | — |
| Human languages (other than | — |
| Analyzer list price | $21, 003.84 (slide maker stainer sold separately) |
| • Analyzer acquisition options | purchase, trade in, lease, cost per reportable contract |
| Training included with purchase/Total time for basic training per operator | <2 min. daily; <2 min. weekly; <2 min. monthly |
| • Follow-up training available | yes (no extra charge) |
| Parameters that analyzer tests and reports | %&# lymphocytes, %&# neutrophils, Hb, Hct, MCHC, MCV, PLT, RBC, WBC |
| Types of testing FDA cleared or approved for analyzer | — |
| Types of body fluids FDA cleared or approved for analysis on analyzer | — |
| Analytical measurement range for body fluid | — |
| Precision for body fluid | — |
| Accuracy for body fluid | — |
| Automated differential performed for body fluids | — |
| Tests available for research use only | — |
| Differential methods used | direct current |
| Analytical measurement range: • WBC count/RBC count | WBC: 1.0–99.9 × 103/μL/RBC: 0.3–7.0 × 106/μL |
| Precision: • WBC count/RBC count | WBC: ≤3.5%/RBC: ≤2.0% |
| Accuracy: • WBC count/RBC count | — |
| Interfering substances: • WBC/RBC | lyse-resistant RBCs, cold agglutinins, cryoglobulins, platelet aggregation, NRBCs/cold agglutinins, severe microcytosis, fragmented RBCs |
| • Hemoglobin/Platelets | severe lipemia, abnormal protein, leukocytosis (>100, 000/μL)/platelet aggregation, giant platelets, microcytic RBCs, fragmented RBCs |
| • Hematocrit/Reticulocytes | cold agglutinins, severe microcytosis, fragmented RBCs/— |
| • Automated differential | — |
| Throughput: max. CBCs per hour/Max. CBCs with differentials per hour | 30/30 |
| • Max. No. of slides processed per hour if stainer included | — |
| FDA-cleared or -approved sample container types (besides potassium EDTA) | none |
| Min. specimen volume open mode/Closed mode/Microsample capability | 15 µL/15 µL/yes |
| Types of patient data archived/Max. No. of archived patient data accessible when analyzer online | flags, histograms/100 samples |
| Analyzer performs delta checks | yes |
| Parameters for which flags may appear | flagging system suggests sample error for WBC, RBC, platelet parameters |
| Analyzer recognizes and holds test results | no |
| Scattergram display uses cell-specific color | no |
| Histogram display uses color with thresholds | yes |
| LIS interface formats supported | ASTM 1381, ASTM 1394-97, RS-232C |
| • Middleware interface | yes (can use company’s middleware or Data Innovations) |
| • Information transferred to LIS via middleware or LIS interface | numeric results, flagged results, histograms, scatterplots, patient demographics, patient orders, host query for patient demographics and orders |
| Analyzer transmits LOINC codes for results to LIS or middleware | no (provides list of machine codes for each test and corresponding LOINC code) |
| Lab automation system or workcells to which analyzer has a direct interface | none |
| Barcode symbologies read on specimen tube | Code 39, Code 128, ASTM, ITF, NW-7, JAN-8, JAN-13 |
| • Analyzer allows barcode placement per CLSI standard Auto02-A2 | no |
| No. of onboard reagents required for standard specimen analysis | 2 |
| • Reagents ready to use/Reagent tracking method | yes/barcode reader |
| Onboard diagnostics for troubleshooting | yes |
| • Manufacturer can perform diagnostics via remote access | yes |
| Warranty provided/Cost of annual service contract (24 h/7 d) | one-year warranty/— |
| Notes | †also marketed by McKesson, Henry Schein |